Anglo American PLC
11 April 2006
News Release
11 April 2006
The offering for AngloGold Ashanti ordinary shares by Anglo South Africa Capital
amounts to 16,328,313 million shares, not 13,328,313 million as previously
announced.
Anglo American plc Announces Offering of Ordinary Shares of AngloGold Ashanti
Anglo American plc today announces that the offering of 16,328,313 AngloGold
Ashanti ordinary shares ("ordinary shares") by its subsidiary, Anglo South
Africa Capital (Proprietary) Limited ("ASAC"), and the offering by AngloGold
Ashanti Limited ("AngloGold Ashanti") of 9,970,732 ordinary shares, in each
case, in the form of ordinary shares or AngloGold Ashanti American Depositary
Shares ("ADSs"), (collectively "the combined offering"), has been priced at
US$51.25 per ADS. The combined offering is scheduled to close on 20 April, 2006.
To the extent that the combined offering has been oversold, ASAC has granted the
underwriters an option to purchase up to an additional 3,944,857 ordinary
shares. The underwriters have 30 days after the closing of the combined offering
to exercise this option. The net proceeds to Anglo American from this offering,
assuming full exercise of the underwriters' option to purchase additional
ordinary shares, are expected to be approximately US$1 billion.
After the completion of the offering, and depending upon the exercise by the
underwriters of their option, Anglo American's holding in AngloGold Ashanti will
be between 41.7% and 43.1%.
The combined offering was led by Goldman, Sachs & Co. and UBS Investment Bank as
joint global coordinators and joint bookrunners for the combined offering. BMO
Nesbitt Burns and J.P. Morgan Securities acted as co-managers.
A final prospectus supplement for the combined offering will be filed with the
U.S. Securities and Exchange Commission as soon as possible. Copies of the final
prospectus supplement and prospectus may be obtained from the offices of
Goldman, Sachs & Co., 85 Broad Street, New York, New York 10004, telephone:
1-866-471-2526 and from UBS Securities LLC, 1285 Avenue of the Americas, New
York, New York 10019-6028, telephone: 1-888-827-7275.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.